History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs.
Fiche publication
Date publication
septembre 2017
Journal
Journal of clinical medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HERBRECHT Raoul, Pr WEBER Jean-Christophe, Pr GOTTENBERG Jacques-Eric
Tous les auteurs :
Andrès E, Mourot-Cottet R, Maloisel F, Keller O, Vogel T, Séverac F, Tebacher M, Gottenberg JE, Weber JC, Kaltenbach G, Goichot B, Sibilia J, Korganow AS, Herbrecht R
Lien Pubmed
Résumé
Despite major advances in its prevention and treatment, febrile neutropenia remains a most concerning complication of cancer chemotherapy. Outside the oncology setting, however, only few data are currently available on febrile neutropenia related to non-chemotherapy drugs. We report here data on 76 patients with febrile neutropenia related to non-chemotherapy drugs, followed up in a referral center within a university hospital.
Mots clés
agranulocytosis, drug, fever, hematopoietic growth factor, infection, neutropenia
Référence
J Clin Med. 2017 Sep;6(10):